Cutaneous lupus erythematosus: Diagnosis and treatment
Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE i...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Okon, L.G. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2013transfer abstract |
|---|
| Schlagwörter: |
Acute cutaneous lupus erythematosus Sub-acute cutaneous lupus erythematosus |
|---|
| Umfang: |
14 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining - 2012transfer abstract, London [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:27 ; year:2013 ; number:3 ; pages:391-404 ; extent:14 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.berh.2013.07.008 |
|---|
| Katalog-ID: |
ELV038617943 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV038617943 | ||
| 003 | DE-627 | ||
| 005 | 20230625222743.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.berh.2013.07.008 |2 doi | |
| 028 | 5 | 2 | |a GBVA2013005000001.pica |
| 035 | |a (DE-627)ELV038617943 | ||
| 035 | |a (ELSEVIER)S1521-6942(13)00060-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 690 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 600 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.73 |2 bkl | ||
| 100 | 1 | |a Okon, L.G. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cutaneous lupus erythematosus: Diagnosis and treatment |
| 264 | 1 | |c 2013transfer abstract | |
| 300 | |a 14 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. | ||
| 520 | |a Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. | ||
| 650 | 7 | |a Acute cutaneous lupus erythematosus |2 Elsevier | |
| 650 | 7 | |a Discoid lupus erythematosus |2 Elsevier | |
| 650 | 7 | |a Sub-acute cutaneous lupus erythematosus |2 Elsevier | |
| 650 | 7 | |a Systemic lupus erythematosus |2 Elsevier | |
| 650 | 7 | |a Treatment |2 Elsevier | |
| 650 | 7 | |a Cutaneous lupus erythematosus |2 Elsevier | |
| 650 | 7 | |a Lupus erythematosus profundus |2 Elsevier | |
| 650 | 7 | |a Chronic cutaneous lupus erythematosus |2 Elsevier | |
| 650 | 7 | |a Lupus erythematosus tumidus |2 Elsevier | |
| 650 | 7 | |a Diagnosis |2 Elsevier | |
| 700 | 1 | |a Werth, V.P. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Baillière Tindall |t Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining |d 2012transfer abstract |g London [u.a.] |w (DE-627)ELV026205912 |
| 773 | 1 | 8 | |g volume:27 |g year:2013 |g number:3 |g pages:391-404 |g extent:14 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.berh.2013.07.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.73 |j Geomedizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 27 |j 2013 |e 3 |h 391-404 |g 14 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
l o lo |
|---|---|
| matchkey_str |
okonlgwerthvp:2013----:uaeulpsrteaoudanss |
| hierarchy_sort_str |
2013transfer abstract |
| bklnumber |
44.73 |
| publishDate |
2013 |
| allfields |
10.1016/j.berh.2013.07.008 doi GBVA2013005000001.pica (DE-627)ELV038617943 (ELSEVIER)S1521-6942(13)00060-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 610 VZ 600 VZ 610 VZ 44.73 bkl Okon, L.G. verfasserin aut Cutaneous lupus erythematosus: Diagnosis and treatment 2013transfer abstract 14 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. Acute cutaneous lupus erythematosus Elsevier Discoid lupus erythematosus Elsevier Sub-acute cutaneous lupus erythematosus Elsevier Systemic lupus erythematosus Elsevier Treatment Elsevier Cutaneous lupus erythematosus Elsevier Lupus erythematosus profundus Elsevier Chronic cutaneous lupus erythematosus Elsevier Lupus erythematosus tumidus Elsevier Diagnosis Elsevier Werth, V.P. oth Enthalten in Baillière Tindall Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining 2012transfer abstract London [u.a.] (DE-627)ELV026205912 volume:27 year:2013 number:3 pages:391-404 extent:14 https://doi.org/10.1016/j.berh.2013.07.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.73 Geomedizin VZ AR 27 2013 3 391-404 14 045F 610 |
| spelling |
10.1016/j.berh.2013.07.008 doi GBVA2013005000001.pica (DE-627)ELV038617943 (ELSEVIER)S1521-6942(13)00060-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 610 VZ 600 VZ 610 VZ 44.73 bkl Okon, L.G. verfasserin aut Cutaneous lupus erythematosus: Diagnosis and treatment 2013transfer abstract 14 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. Acute cutaneous lupus erythematosus Elsevier Discoid lupus erythematosus Elsevier Sub-acute cutaneous lupus erythematosus Elsevier Systemic lupus erythematosus Elsevier Treatment Elsevier Cutaneous lupus erythematosus Elsevier Lupus erythematosus profundus Elsevier Chronic cutaneous lupus erythematosus Elsevier Lupus erythematosus tumidus Elsevier Diagnosis Elsevier Werth, V.P. oth Enthalten in Baillière Tindall Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining 2012transfer abstract London [u.a.] (DE-627)ELV026205912 volume:27 year:2013 number:3 pages:391-404 extent:14 https://doi.org/10.1016/j.berh.2013.07.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.73 Geomedizin VZ AR 27 2013 3 391-404 14 045F 610 |
| allfields_unstemmed |
10.1016/j.berh.2013.07.008 doi GBVA2013005000001.pica (DE-627)ELV038617943 (ELSEVIER)S1521-6942(13)00060-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 610 VZ 600 VZ 610 VZ 44.73 bkl Okon, L.G. verfasserin aut Cutaneous lupus erythematosus: Diagnosis and treatment 2013transfer abstract 14 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. Acute cutaneous lupus erythematosus Elsevier Discoid lupus erythematosus Elsevier Sub-acute cutaneous lupus erythematosus Elsevier Systemic lupus erythematosus Elsevier Treatment Elsevier Cutaneous lupus erythematosus Elsevier Lupus erythematosus profundus Elsevier Chronic cutaneous lupus erythematosus Elsevier Lupus erythematosus tumidus Elsevier Diagnosis Elsevier Werth, V.P. oth Enthalten in Baillière Tindall Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining 2012transfer abstract London [u.a.] (DE-627)ELV026205912 volume:27 year:2013 number:3 pages:391-404 extent:14 https://doi.org/10.1016/j.berh.2013.07.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.73 Geomedizin VZ AR 27 2013 3 391-404 14 045F 610 |
| allfieldsGer |
10.1016/j.berh.2013.07.008 doi GBVA2013005000001.pica (DE-627)ELV038617943 (ELSEVIER)S1521-6942(13)00060-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 610 VZ 600 VZ 610 VZ 44.73 bkl Okon, L.G. verfasserin aut Cutaneous lupus erythematosus: Diagnosis and treatment 2013transfer abstract 14 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. Acute cutaneous lupus erythematosus Elsevier Discoid lupus erythematosus Elsevier Sub-acute cutaneous lupus erythematosus Elsevier Systemic lupus erythematosus Elsevier Treatment Elsevier Cutaneous lupus erythematosus Elsevier Lupus erythematosus profundus Elsevier Chronic cutaneous lupus erythematosus Elsevier Lupus erythematosus tumidus Elsevier Diagnosis Elsevier Werth, V.P. oth Enthalten in Baillière Tindall Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining 2012transfer abstract London [u.a.] (DE-627)ELV026205912 volume:27 year:2013 number:3 pages:391-404 extent:14 https://doi.org/10.1016/j.berh.2013.07.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.73 Geomedizin VZ AR 27 2013 3 391-404 14 045F 610 |
| allfieldsSound |
10.1016/j.berh.2013.07.008 doi GBVA2013005000001.pica (DE-627)ELV038617943 (ELSEVIER)S1521-6942(13)00060-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 610 VZ 600 VZ 610 VZ 44.73 bkl Okon, L.G. verfasserin aut Cutaneous lupus erythematosus: Diagnosis and treatment 2013transfer abstract 14 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. Acute cutaneous lupus erythematosus Elsevier Discoid lupus erythematosus Elsevier Sub-acute cutaneous lupus erythematosus Elsevier Systemic lupus erythematosus Elsevier Treatment Elsevier Cutaneous lupus erythematosus Elsevier Lupus erythematosus profundus Elsevier Chronic cutaneous lupus erythematosus Elsevier Lupus erythematosus tumidus Elsevier Diagnosis Elsevier Werth, V.P. oth Enthalten in Baillière Tindall Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining 2012transfer abstract London [u.a.] (DE-627)ELV026205912 volume:27 year:2013 number:3 pages:391-404 extent:14 https://doi.org/10.1016/j.berh.2013.07.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.73 Geomedizin VZ AR 27 2013 3 391-404 14 045F 610 |
| language |
English |
| source |
Enthalten in Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining London [u.a.] volume:27 year:2013 number:3 pages:391-404 extent:14 |
| sourceStr |
Enthalten in Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining London [u.a.] volume:27 year:2013 number:3 pages:391-404 extent:14 |
| format_phy_str_mv |
Article |
| bklname |
Geomedizin |
| institution |
findex.gbv.de |
| topic_facet |
Acute cutaneous lupus erythematosus Discoid lupus erythematosus Sub-acute cutaneous lupus erythematosus Systemic lupus erythematosus Treatment Cutaneous lupus erythematosus Lupus erythematosus profundus Chronic cutaneous lupus erythematosus Lupus erythematosus tumidus Diagnosis |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining |
| authorswithroles_txt_mv |
Okon, L.G. @@aut@@ Werth, V.P. @@oth@@ |
| publishDateDaySort_date |
2013-01-01T00:00:00Z |
| hierarchy_top_id |
ELV026205912 |
| dewey-sort |
3610 |
| id |
ELV038617943 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV038617943</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625222743.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.berh.2013.07.008</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013005000001.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV038617943</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1521-6942(13)00060-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">600</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.73</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Okon, L.G.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cutaneous lupus erythematosus: Diagnosis and treatment</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">14</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Acute cutaneous lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Discoid lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sub-acute cutaneous lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Systemic lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Treatment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cutaneous lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lupus erythematosus profundus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chronic cutaneous lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lupus erythematosus tumidus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diagnosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Werth, V.P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Baillière Tindall</subfield><subfield code="t">Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining</subfield><subfield code="d">2012transfer abstract</subfield><subfield code="g">London [u.a.]</subfield><subfield code="w">(DE-627)ELV026205912</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:27</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:391-404</subfield><subfield code="g">extent:14</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.berh.2013.07.008</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.73</subfield><subfield code="j">Geomedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">27</subfield><subfield code="j">2013</subfield><subfield code="e">3</subfield><subfield code="h">391-404</subfield><subfield code="g">14</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Okon, L.G. |
| spellingShingle |
Okon, L.G. ddc 610 ddc 690 ddc 600 bkl 44.73 Elsevier Acute cutaneous lupus erythematosus Elsevier Discoid lupus erythematosus Elsevier Sub-acute cutaneous lupus erythematosus Elsevier Systemic lupus erythematosus Elsevier Treatment Elsevier Cutaneous lupus erythematosus Elsevier Lupus erythematosus profundus Elsevier Chronic cutaneous lupus erythematosus Elsevier Lupus erythematosus tumidus Elsevier Diagnosis Cutaneous lupus erythematosus: Diagnosis and treatment |
| authorStr |
Okon, L.G. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV026205912 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 690 - Buildings 600 - Technology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 690 VZ 610 VZ 600 VZ 44.73 bkl Cutaneous lupus erythematosus: Diagnosis and treatment Acute cutaneous lupus erythematosus Elsevier Discoid lupus erythematosus Elsevier Sub-acute cutaneous lupus erythematosus Elsevier Systemic lupus erythematosus Elsevier Treatment Elsevier Cutaneous lupus erythematosus Elsevier Lupus erythematosus profundus Elsevier Chronic cutaneous lupus erythematosus Elsevier Lupus erythematosus tumidus Elsevier Diagnosis Elsevier |
| topic |
ddc 610 ddc 690 ddc 600 bkl 44.73 Elsevier Acute cutaneous lupus erythematosus Elsevier Discoid lupus erythematosus Elsevier Sub-acute cutaneous lupus erythematosus Elsevier Systemic lupus erythematosus Elsevier Treatment Elsevier Cutaneous lupus erythematosus Elsevier Lupus erythematosus profundus Elsevier Chronic cutaneous lupus erythematosus Elsevier Lupus erythematosus tumidus Elsevier Diagnosis |
| topic_unstemmed |
ddc 610 ddc 690 ddc 600 bkl 44.73 Elsevier Acute cutaneous lupus erythematosus Elsevier Discoid lupus erythematosus Elsevier Sub-acute cutaneous lupus erythematosus Elsevier Systemic lupus erythematosus Elsevier Treatment Elsevier Cutaneous lupus erythematosus Elsevier Lupus erythematosus profundus Elsevier Chronic cutaneous lupus erythematosus Elsevier Lupus erythematosus tumidus Elsevier Diagnosis |
| topic_browse |
ddc 610 ddc 690 ddc 600 bkl 44.73 Elsevier Acute cutaneous lupus erythematosus Elsevier Discoid lupus erythematosus Elsevier Sub-acute cutaneous lupus erythematosus Elsevier Systemic lupus erythematosus Elsevier Treatment Elsevier Cutaneous lupus erythematosus Elsevier Lupus erythematosus profundus Elsevier Chronic cutaneous lupus erythematosus Elsevier Lupus erythematosus tumidus Elsevier Diagnosis |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
v w vw |
| hierarchy_parent_title |
Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining |
| hierarchy_parent_id |
ELV026205912 |
| dewey-tens |
610 - Medicine & health 690 - Building & construction 600 - Technology |
| hierarchy_top_title |
Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV026205912 |
| title |
Cutaneous lupus erythematosus: Diagnosis and treatment |
| ctrlnum |
(DE-627)ELV038617943 (ELSEVIER)S1521-6942(13)00060-0 |
| title_full |
Cutaneous lupus erythematosus: Diagnosis and treatment |
| author_sort |
Okon, L.G. |
| journal |
Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining |
| journalStr |
Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
zzz |
| container_start_page |
391 |
| author_browse |
Okon, L.G. |
| container_volume |
27 |
| physical |
14 |
| class |
610 610 DE-600 690 VZ 610 VZ 600 VZ 44.73 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Okon, L.G. |
| doi_str_mv |
10.1016/j.berh.2013.07.008 |
| dewey-full |
610 690 600 |
| title_sort |
cutaneous lupus erythematosus: diagnosis and treatment |
| title_auth |
Cutaneous lupus erythematosus: Diagnosis and treatment |
| abstract |
Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. |
| abstractGer |
Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. |
| abstract_unstemmed |
Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
3 |
| title_short |
Cutaneous lupus erythematosus: Diagnosis and treatment |
| url |
https://doi.org/10.1016/j.berh.2013.07.008 |
| remote_bool |
true |
| author2 |
Werth, V.P. |
| author2Str |
Werth, V.P. |
| ppnlink |
ELV026205912 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1016/j.berh.2013.07.008 |
| up_date |
2024-07-06T18:42:23.161Z |
| _version_ |
1803856215447437312 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV038617943</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625222743.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.berh.2013.07.008</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013005000001.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV038617943</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1521-6942(13)00060-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">600</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.73</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Okon, L.G.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cutaneous lupus erythematosus: Diagnosis and treatment</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">14</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Acute cutaneous lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Discoid lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sub-acute cutaneous lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Systemic lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Treatment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cutaneous lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lupus erythematosus profundus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chronic cutaneous lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lupus erythematosus tumidus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diagnosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Werth, V.P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Baillière Tindall</subfield><subfield code="t">Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining</subfield><subfield code="d">2012transfer abstract</subfield><subfield code="g">London [u.a.]</subfield><subfield code="w">(DE-627)ELV026205912</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:27</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:391-404</subfield><subfield code="g">extent:14</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.berh.2013.07.008</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.73</subfield><subfield code="j">Geomedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">27</subfield><subfield code="j">2013</subfield><subfield code="e">3</subfield><subfield code="h">391-404</subfield><subfield code="g">14</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.399867 |